WHO ICTRP trial
addition of two different drugs Buprenorphine or Dexamethasone to…
CTRI/2017/10/010081 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2017/10/010081 |
|---|---|
| Public title | addition of two different drugs Buprenorphine or Dexamethasone to Levobupivacaine in TAP block may or may not provide better pain control in inguinal hernia repair |
| Scientific title | "Effect of addition of Buprenorphine or Dexamethasone to Levobupivacaine on postoperative analgesia in ultrasound guided Transversus Abdominis Plane block for Inguinal hernia repair: A prospective double blind randomized control trial" - TAP |
| Primary sponsor | Dr S N medical collage and attached hospital Jodhpur |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: null- ASA grade 1 and 2 |
| Interventions | Intervention1: Buprenorphine: GROUP LB: Patient will receive 20 ml 0.25% inj. levobupivacaine + 1 ml inj. buprenorphine (.3mg/ml) with total volume of 21 ml. Intervention2: Dexamethasone: GROUP LD: Patient will receive 20 ml 0.25% inj… |
| Registration date | Dec 10, 2017 |
| Target size | 93 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: